Comparing the Effect of Vaginal Misoprostol With Dinoprostone in Term Pregnancies
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Hypothesis (H0): Labor duration and obstetric complications are not significantly different in the three groups (misoprostol-dinoprostone-oxytocin).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2007
CompletedFirst Posted
Study publicly available on registry
February 8, 2007
CompletedJune 1, 2007
February 1, 2007
February 6, 2007
May 31, 2007
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Term pregnancy
- Singleton
- Vertex
- Bishop score below 6
You may not qualify if:
- History of drug reaction
- Medical disease
- IUGR
- Oligohydramnios
- Vaginal bleeding
- Fetal anomaly
- Uterine scar
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shariaty Maternity Hospital
Tehran, Iran
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mitra Ahmad Soltani
Hormozgan University of Medical Sciences
- STUDY CHAIR
Minoo Rajaee Lari, Perinatologist - Obs and Gyn
Department of Obs and Gyn - HUMS
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 6, 2007
First Posted
February 8, 2007
Last Updated
June 1, 2007
Record last verified: 2007-02